Literature DB >> 21944082

Changes in cancer volume in serial biopsies of men on active surveillance for early stage prostate cancer.

Sima P Porten1, Jared M Whitson, Janet E Cowan, Nannette Perez, Katsuto Shinohara, Peter R Carroll.   

Abstract

PURPOSE: We described changes in tumor volume on serial biopsies during an extended period in men on active surveillance.
MATERIALS AND METHODS: The study cohort included men diagnosed with prostate cancer between 1998 and 2010 enrolled in active surveillance with 6 or more months of followup. Change in volume over time was assessed as change in percent cores positive, percent cancer in 1 biopsy core and the doubling of total cancer volume (mm). Logistic regression was used to determine the association between grade and volume progression.
RESULTS: A total of 399 men met the study inclusion criteria. Mean patient age was 61.8 years old and 313 (78%) had low risk disease. Overall 231 (58%) men had stable disease on repeat biopsies. There were 39 (10%) men with a volume increase, defined by an increase to more than 33% cores involved or an increase in maximum single core positive to more than 50%, and there were 44 (11%) with an increase in volume and grade. Approximately 10% of men experienced a decrease in cancer volume. On multivariate analysis there was a significant association between grade and volume progression on any biopsy (OR 3.07), and a doubling of tumor length (mm) at 5 years (OR 6.30).
CONCLUSIONS: Prostate cancer volume increases and decreases at a similar rate of 10% per biopsy. An increase in tumor volume is associated with an increase in cancer grade on early repeat biopsies. However, there is a large degree of variation in cancer volume over time.
Copyright © 2011 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21944082     DOI: 10.1016/j.juro.2011.06.055

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer.

Authors:  Katsuyoshi Hashine; Hiroyuki Iio; Yoshiteru Ueno; Shohei Tsukimori; Iku Ninomiya
Journal:  Int J Clin Oncol       Date:  2013-06-22       Impact factor: 3.402

2.  Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancer.

Authors:  Geoffrey A Sonn; Christopher P Filson; Edward Chang; Shyam Natarajan; Daniel J Margolis; Malu Macairan; Patricia Lieu; Jiaoti Huang; Frederick J Dorey; Robert E Reiter; Leonard S Marks
Journal:  Urol Oncol       Date:  2014-07-11       Impact factor: 3.498

3.  Population-based study of grade progression in patients who harboured Gleason 3 + 3.

Authors:  Fanny Sampurno; Arul Earnest; Jeremy Millar; Mark Frydenberg; Declan Murphy; Warwick Delprado; Sue Evans
Journal:  World J Urol       Date:  2017-05-12       Impact factor: 4.226

Review 4.  Meaningful end points and outcomes in men on active surveillance for early-stage prostate cancer.

Authors:  Christopher J Welty; Matthew R Cooperberg; Peter R Carroll
Journal:  Curr Opin Urol       Date:  2014-05       Impact factor: 2.309

5.  In-bore MRI-guided biopsy: can it optimize the need for periodic biopsies in prostate cancer patients undergoing active surveillance? A pilot test-retest reliability study.

Authors:  Kareem K Elfatairy; Christopher P Filson; Martin G Sanda; Adeboye O Osunkoya; Rachel L Geller; Sherif G Nour
Journal:  Br J Radiol       Date:  2018-02-13       Impact factor: 3.039

6.  The performance of PI-RADSv2 and quantitative apparent diffusion coefficient for predicting confirmatory prostate biopsy findings in patients considered for active surveillance of prostate cancer.

Authors:  Stephanie Nougaret; Nicola Robertson; Jennifer Golia Pernicka; Nicolas Molinari; Andreas M Hötker; Behfar Ehdaie; Evis Sala; Hedvig Hricak; Hebert Alberto Vargas
Journal:  Abdom Radiol (NY)       Date:  2017-07

Review 7.  Active surveillance for prostate cancer: overview and update.

Authors:  Laurence Klotz
Journal:  Curr Treat Options Oncol       Date:  2013-03

8.  Image-based monitoring of targeted biopsy-proven prostate cancer on active surveillance: 11-year experience.

Authors:  Sunao Shoji; Osamu Ukimura; Andre Luis de Castro Abreu; Arnaud Marien; Toru Matsugasumi; Duke Bahn; Inderbir S Gill
Journal:  World J Urol       Date:  2015-06-21       Impact factor: 3.661

Review 9.  Magnetic resonance imaging-transrectal ultrasound fusion image-guided prostate biopsy: Current status of the cancer detection and the prospects of tailor-made medicine of the prostate cancer.

Authors:  Sunao Shoji
Journal:  Investig Clin Urol       Date:  2018-12-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.